A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Homtex, Receives FDA Approval For Its Level 1 Surgical Masks

March 15, 2021

HomTex, an Alabama-based, minority-certified textile manufacturer manufactures 3-ply disposable masks and reusable cloth masks, which it supplies to the US Capitol, and soon will produce NIOSH N-95 masks in a new plant in Selma, Alabama.

HomTex is now positioned to have the largest capacity in the US to produce 100 percent made-in-America masks with facilities in Cullman and Mobile, Alabama; Tennessee; South Carolina; and North Carolina.

Jerry Wooten, CEO of HomTex, said “When I say made in America, I mean every component sourced in the US and made in the US.  We believe that ramping up domestic manufacturing of PPE products is a national imperative from a safety, economic, and national security perspective, and HomTex is proud to meet that challenge.”

While hospitals and governments have been struggling to provide safe PPE for Americans, defective and fraudulent masks, often made in China, have flooded the US market. According to the Associated Press, federal law enforcement has seized 10 million counterfeit N95 masks alone, and the US Customs and Border Patrol announced in June 2020 that it seized 750,000 counterfeit face masks in 86 incidents.  Due to emergency procurement rules put in place during the pandemic, China and other bad actors have access to the US market that otherwise would be banned.  By selling defective and counterfeit masks at rock-bottom prices, fraudsters are exploiting US buyers with unsafe PPE and undermining US-made manufacturing.

According to Wooten, “It’s time for purchasers of critical PPE – particularly federal, state, and local governments – to wake up to the fact that Chinese and foreign-made masks are cheaper, but likely defective, counterfeit, and plain-old dangerous. It’s important to buy safe, genuine, and approved PPE from a trusted made-in-America manufacturer.  We are proud to be a strategic provider to the Architect of the US Capitol which supplies masks to the US House of Representatives, the US Capitol, and the US Senate.”

“We are immensely proud of all HomTex is doing to produce PPE,” said Katie Boyd Britt, President of the Business Council of Alabama. “Receiving this critical authorization from the FDA allows them to expand their PPE offerings and to keep Americans safe. We are thrilled to be a trusted partner as they expand their operations in Selma.”

HomTex has the capacity to produce 700 million surgical 3-ply masks and 20 million NIOSH N-95 masks annually.  HomTex will open an additional manufacturing facility in Selma, AL in the Fall of 2021 that will create 300 jobs for the most economically disadvantaged region of Alabama.

SourceHomTex
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy